[ Home ] [ Controlled Substances ] [ Depressants ]
OXAZOLAM
|

https://drugster.org/anxiolytic-sedatives-hypnotics-and-antipsychotics/oxazolam
Oxazolam is a prodrug (precursor) for the benzodiazepine desmethyl-diazepam (nordazepam) and is itself a metabolic product of other benzodiazepines. It has anxiolytic, sedative, and anticonvulsant properties. It is a GABA-A receptor agonist. Oxazolam is marketed in Japan under the brand name Serenal. It is usually used to treat anxiety, tension, depression, and sleeping disorder in neurosis. It is used to treat somatic symptoms in psychosomatic disorders (gastrointestinal diseases, circulatory diseases, endocrine diseases, and autonomic dystonia), anxiety, tension, and depression. It is also used as a preanesthetic medication.
Oxazolam:
https://drugs.ncats.io/drug/1V2WI2NA1C
Duration: | |||
Route | Onset | Duration | After Effects |
---|---|---|---|
Tripsit Factsheets | |||
![]() Oxazolam Basic Information: http://drugs.tripsit.me/oxazolam | |||
All ROAs: | 30-90 minutes | 6-12 hours | 6-12 hours |
![]() |
Anxiolytic, anticonvulsant, sedative, and skeletal muscle relaxant properties.
Psychomotor Effects of Mexazolam vs. Placebo - Medscape - Objective: Mexazolam is an oxazolo-benzodiazepine demonstrating chemical similarities to oxazolam and cloxazolam. This trial aimed to assess the effect of mexazolam on psychomotor performance ... Sunday June 22, 2025 - medscape.com Global Oxazolam Market 2020 Growth Analysis, Opportunities, Trends and Developments to 2025 - Global Oxazolam Market 2020 by Manufacturers, Type and Application, Forecast to 2025, a new addition to the catalog of MarketsandResearch.biz, contains a set of essential analyses related to the ... Global Oxazolam Market 2020: Industry Demand, Insight & Forecast By 2025 - The research report titled Global Oxazolam Market Growth 2020-2025 added by MarketandResearch.biz exhibits detailed information and an overview of the key influential factors required to make a ...
| ||
Depressants | Link to this page |